NCT07151079 TAG TEAM - Trans Adolescent Group Therapy
| NCT ID | NCT07151079 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Murdoch Childrens Research Institute |
| Condition | Minority Stress |
| Study Type | INTERVENTIONAL |
| Enrollment | 142 participants |
| Start Date | 2026-05-21 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 142 participants in total. It began in 2026-05-21 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will study the effect of the TAG TEAM group CBT program on the mental health of trans and gender diverse adolescents. TAG TEAM was co-designed by researchers and clinicians with a group of trans and gender diverse young people to help trans and gender diverse adolescents understand and cope with minority stress. Minority stress includes experiences like discrimination and rejection. TAG TEAM focuses on learning and practicing skills to support mental health and wellbeing. It also includes group discussions and activities with other trans and gender diverse young people. TAG TEAM groups are run by a psychologist and a trans peer facilitator. A trans peer facilitator is a trans and gender diverse person who is there to share their experience of being trans and to support participants in the group sessions.
Eligibility Criteria
Participants will be enrolled into the RCT only if they meet all the inclusion criteria and none of the exclusion criteria. Inclusion Criteria: * Identifies as trans, non-binary, or gender diverse * Is between the ages of 12 and 17 years inclusive * Has completed primary school at the time of enrolment into the study * Has current psychological stress symptomology as determined by a score of moderate or above on the DASS-Y * Provide informed consent: All participants and parent/legal guardians must be willing to give informed consent Exclusion Criteria: * Has current acute suicidal symptomology as determined by a combination of clinical judgement and the results of the Ask Suicide-Screening Questions (ASQ) suicide screening tool (e.g., answer yes to question 5) to determine the risk of suicide (has an active plan and/or intent to suicide) at time of screening interview * Is actively having treatment with any other group psychological intervention at the time of enrolment into the study * Is not proficient in English (as the group Cognitive behaviour therapy (CBT) program will be delivered in English and funds aren't available for interpreters) * Previous participation in the feasibility trial * Is currently enrolled in tertiary study (e.g., undergraduate university)
Contact & Investigator
Timothy J Cronin, PhD
PRINCIPAL INVESTIGATOR
Murdoch Childrens Research Institute
Frequently Asked Questions
Who can join the NCT07151079 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Minority Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07151079 currently recruiting?
Yes, NCT07151079 is actively recruiting participants. Contact the research team at tagteam@mcri.edu.au for enrollment information.
Where is the NCT07151079 trial being conducted?
This trial is being conducted at Parkville, Australia.
Who is sponsoring the NCT07151079 clinical trial?
NCT07151079 is sponsored by Murdoch Childrens Research Institute. The principal investigator is Timothy J Cronin, PhD at Murdoch Childrens Research Institute. The trial plans to enroll 142 participants.